Literature DB >> 11190797

Primary lymph node plasmacytomas (plasmacytic lymphomas).

D M Menke1, H P Horny, H Griesser, M Tiemann, J A Katzmann, E Kaiserling, R Parwaresch, R A Kyle.   

Abstract

To determine whether primary lymph node plasmacytoma (PLNP) is a distinct entity among other types of plasma cell neoplasia, we analyzed a large series of PLNPs from 2 large lymphoma registries to compare histologic, immunophenotypic, and clinical features of PLNPs, nonnodal extramedullary plasmacytomas, and multiple myeloma. Twenty-five PLNPs (clinical data on 15 cases) were compared with 10 non-lymph node plasmacytomas and 51 cases of multiple myeloma; 36 cases of reactive plasmacytoses were used as controls. The histologic features of PLNP and other extramedullary plasmacytomas were similar. The histologic features of PLNPs were more immature than those of reactive plasmacytoses and less immature than in multiple myeloma. The immunophenotype of PLNPs significantly differed from that of reactive plasmacytoses, other extramedullary plasmacytomas, and multiple myeloma. PLNPs did not progress to multiple myeloma, unlike other extramedullary plasmacytomas, even though survival in PLNPs and other extramedullary plasmacytomas was similar. Our findings suggest that PLNPs may be distinct from other plasma cell dyscrasias.

Entities:  

Mesh:

Year:  2001        PMID: 11190797     DOI: 10.1309/L2GR-PCFM-G4A3-GHDW

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

2.  Synchronous presentation of a primary iliac lymph node plasmacytoma and a prostate adenocarcinoma.

Authors:  Eiko Klimant; Daniela M Albu; Maurie Markman
Journal:  Case Rep Oncol       Date:  2011-06-20

3.  A case of primary plasmacytoma of lymph nodes.

Authors:  Young Hyo Lim; Su Kyoung Park; Ho Suk Oh; Jung Hye Choi; Myung Ju Ahn; Young Yul Lee; In Soon Kim
Journal:  Korean J Intern Med       Date:  2005-06       Impact factor: 2.884

4.  Unusual course of generalized lymph node primary plasmacytoma in a patient with Sjögren's syndrome: a case report.

Authors:  Vadim R Gorodetskiy; Natalya A Probatova; Vladimir I Vasilyev
Journal:  J Med Case Rep       Date:  2017-04-20

5.  Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment.

Authors:  Man Fai Law; Hay Nun Chan; Charlotte Leung; Cheuk Kei Wong; Ho Kei Lai; Chung Yin Ha; Celia Ng; Yiu Ming Yeung; Sze Fai Yip
Journal:  Arch Med Sci       Date:  2017-04-20       Impact factor: 3.318

6.  Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance.

Authors:  Hai-Fei Chen; Tian-Qin Wu; Zheng-Yang Li; Hong-Shi Shen; Jie-Qing Tang; Wei-Jun Fu; Zhen-Gang Yuan; Jian Hou
Journal:  Onco Targets Ther       Date:  2012-11-07       Impact factor: 4.147

7.  Remarkable Response to Methylprednisolone in a Multiple Myeloma Patient with Nodal Disease Refractory to High-Dose Chemotherapy.

Authors:  Kimberly Celotto; Vishala Neppalli; Sarah Holstein
Journal:  Cureus       Date:  2015-12-16

8.  Unicentric mixed variant Castleman disease associated with intrabronchial plasmacytoma.

Authors:  Noémi Eszes; Lilla Tamási; Attila Csekeő; Judit Csomor; Agota Szepesi; Gergely Varga; György Balázs; György Losonczy; Veronika Müller
Journal:  Diagn Pathol       Date:  2014-03-20       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.